Biglycan is an extracellular MuSK binding protein important for synapse stability

Journal of Neuroscience

Volumn 32, Issue 7, 2012, Pages 2324-2334

  Amenta, Alison R ^a   Creely, Hilliary E ^a,b   Mercado, Mary Lynn T ^a   Hagiwara, Hiroki ^a   McKechnie, Beth A ^a   Lechner, Beatrice E ^a   Rossi, Susana G ^c   Wang, Qiang ^d   Owens, Rick T ^e   Marrero, Emilio ^c   Mei, Lin ^d   Hoch, Werner ^f   Young, Marian F ^g   McQuillan, David J ^e   Rotundo, Richard L ^c   Fallon, Justin R ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e LIFECELL CORPORATION   (United States)

^f University of Houston   (United States)

^g NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BIGLYCAN; CHOLINERGIC RECEPTOR; PROTEIN TYROSINE KINASE; RECEPTOR TYROSINE KINASE MUSK; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; MYOTUBE; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SYNAPTOGENESIS;

ANIMALS; BIGLYCAN; CELL DIFFERENTIATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; EXTRACELLULAR FLUID; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; PROTEIN STABILITY; RECEPTOR PROTEIN-TYROSINE KINASES; SYNAPSES;

EID: 84863164982     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4610-11.2012     Document Type: Article

References (64)

1. Adams ME, Kramarcy N, Fukuda T, Engel AG, Sealock R, Froehner SC (2004) Structural abnormalities at neuromuscular synapses lacking multiple syntrophin isoforms. J Neurosci 24:10302-10309.
2. Amenta AR, Yilmaz A, Bogdanovich S, McKechnie BA, Abedi M, Khurana TS, Fallon JR (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A 108:762-767.
3. Ameye L, Young MF (2002) Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12:107R-116R.
4. Anglister L, McMahan UJ (1985) Basal lamina directs acetylcholinesterase accumulation at synaptic sites in regenerating muscle. J Cell Biol 101:735-743.
5. Balice-Gordon RJ, Lichtman JW (1990) In vivo visualization of the growth of pre- and postsynaptic elements of neuromuscular junctions in the mouse. J Neurosci 10:894-908.
6. Bowe MA, Mendis DB, Fallon JR (2000) The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J Cell Biol 148:801-810.
7. Burden SJ (2002) Building the vertebrate neuromuscular synapse. J Neurobiol 53:501-511.
8. Burden SJ, Sargent PB, McMahan UJ (1979) Acetylcholine receptors in regenerating muscle accumulate at original synaptic sites in the absence of the nerve. J Cell Biol 82:412-425.
9. Cartaud A, Strochlic L, Guerra M, Blanchard B, Lambergeon M, Krejci E, Cartaud J, Legay C (2004) MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J Cell Biol 165:505-515.
10. Casar JC, McKechnie BA, Fallon JR, Young MF, Brandan E (2004) Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol 268:358-371.
11. Chen F, Liu Y, Sugiura Y, Allen PD, Gregg RG, Lin W (2011) Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors. Nat Neurosci 14:570-577.
12. Coggan JS, Grutzendler J, Bishop DL, Cook MR, Gan W, Heym J, Lichtman JW (2004) Age-associated synapse elimination in mouse parasympathetic ganglia. J Neurobiol 60:214-226.
13. Fallon JR, Nitkin RM, Reist NE, Wallace BG, McMahan UJ (1985) Acetylcholine receptor-aggregating factor is similar to molecules concentrated at neuromuscular junctions. Nature 315:571-574.
14. Feng G, Krejci E, Molgo J, Cunningham JM, Massoulié J, Sanes JR (1999) Genetic analysis of collagen Q: Roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol 144:1349-1360.
15. Ferns MJ, Campanelli JT, Hoch W, Scheller RH, Hall Z (1993) The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycans. Neuron 11:491-502.
16. Fox MA, Sanes JR, Borza DB, Eswarakumar VP, Fässler R, Hudson BG, John SW, Ninomiya Y, Pedchenko V, Pfaff SL, Rheault MN, Sado Y, Segal Y, Werle MJ, Umemori H (2007) Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals. Cell 129:179-193.
17. Ganju P, Walls E, Brennan J, Reith AD (1995) Cloning and developmental expression of Nsk2, a novel receptor tyrosine kinase implicated in skeletal myogenesis. Oncogene 11:281-290.
18. Glass DJ, DeChiara TM, Bowen DC, Stitt TN, Radziejewski C, Bruno J-A, Ryan TE, Gies DR, Shah S, Burden SJ, DiStefano PS, Valenzuela DM, Yancopoulos GD (1996a) The receptor tyrosine kinase, MuSK, is required for neuromuscular junction formation in vivo, and is a component of a receptor complex for agrin. Soc Neurosci Abstr 22:1476.
19. Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, Gies DR, Shah S, Mattsson K, Burden SJ, DiStefano PS, Valenzuela DM, DeChiara TM, Yancopoulos GD (1996b) Agrin acts via a MuSK receptor complex. Cell 85:513-523.
20. Godfrey EW, Nitkin RM, Wallace BG, Rubin LL, McMahan UJ (1984) Components of Torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells. J Cell Biol 99:615-627.
21. Gordon H, Hall ZW (1989) Glycosaminoglycan variants in the C2 muscle cell line. Dev Biol 135:1-11.
22. Grady RM, Akaaboune M, Cohen AL, Maimone MM, Lichtman JW, Sanes JR (2003) Tyrosine-phosphorylated and nonphosphorylated isoforms of alpha-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions. J Cell Biol 160:741-752.
23. Hall ZW (1973) Multiple forms of acetylcholinesterase and their distribution in endplate and non-endplate regions of rat diaphragm muscle. J Neurobiol 4:343-361.
24. Herbst R, Burden SJ (2000) The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J 19:67-77.
25. Holt KH, Campbell KP (1998) Assembly of the sarcoglycan complex. Insights for muscular dystrophy. J Biol Chem 273:34667-34670.
26. Hopf C, Hoch W (1998) Tyrosine phosphorylation of the muscle-specific kinase is exclusively induced by acetylcholine receptor-aggregating agrin fragments. Eur J Biochem 253:382-389.
27. Hrabovska A, Bernard V, Krejci E (2010) A novel system for the efficient generation of antibodies following immunization of unique knockout mouse strains. PLoS One 5:e12892.
28. Jing L, Lefebvre JL, Gordon LR, Granato M (2009) Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/MuSK receptor. Neuron 61:721-733.
29. Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML, Burden SJ (2008) Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135:334-342.
30. Kong XC, Barzaghi P, Ruegg MA (2004) Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep 5:183-188.
31. Krishnan P, Hocking AM, Scholtz JM, Pace CN, Holik KK, McQuillan DJ (1999) Distinct secondary structures of the leucine-rich repeat proteoglycans decorin and biglycan. Glycosylation-dependent conformational stability. J Biol Chem 274:10945-10950.
32. Kummer TT, Misgeld T, Sanes JR (2006) Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol 16:74-82.
33. Lechner BE, Lim JH, Mercado ML, Fallon JR (2006) Developmental regulation of biglycan expression in muscle and tendon. Muscle Nerve 34:347-355.
34. Legay C (2000) Why so many forms of acetylcholinesterase? Microsc Res Tech 49:56-72.
35. Lichtman JW, Magrassi L, Purves D (1987) Visualization of neuromuscular junctions over periods of several months in living mice. J Neurosci 7:1215-1222.
36. Lwebuga-Mukasa JS, Lappi S, Taylor P (1976) Molecular forms of acetylcholinesterase from Torpedo californica: their relationship to synaptic membranes. Biochemistry 15:1425-1434.
37. Marques MJ, Conchello JA, Lichtman JW (2000) From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J Neurosci 20:3663-3675.
38. Marshall LM, Sanes JR, McMahan UJ (1977) Reinnervation of original synaptic sites on muscle fiber basement membrane after disruption of the muscle cells. Proc Natl Acad Sci U S A 74:3073-3077.
39. Masiakowski P, Yancopoulos GD (1998) The Wnt receptor CRD domain is also found in MuSK and related orphan receptor tyrosine kinases [letter]. Curr Biol 8:R407.
40. McEwan PA, Scott PG, Bishop PN, Bella J (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 155:294-305.
41. McMahan UJ, Sanes JR, Marshall LM (1978) Cholinesterase is associated with the basal lamina at the neuromuscular junction. Nature 271:172-174.
42. Megeath LJ, Fallon JR (1998) Intracellular calcium regulates agrin-induced acetylcholine receptor clustering. J Neurosci 18:672-678.
43. Mercado ML, Amenta AR, Hagiwara H, Rafii MS, Lechner BE, Owens RT, McQuillan DJ, Froehner SC, Fallon JR (2006) Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J 20:1724-1726.
44. Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat PS, Noble MD, Farmer K, Partridge TA (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Developmental Biology 162:486-498.
45. Nitkin RM, Smith MA, Magill C, Fallon JR, Yao YM, Wallace BG, McMahan UJ (1987) Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J Cell Biol 105:2471-2478.
46. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M (2005) Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 32:563-576.
47. Peng HB, Xie H, Rossi SG, Rotundo RL (1999) Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145:911-921.
48. Punga AR, Lin S, Oliveri F, Meinen S, Rüegg MA (2011) Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice. Exp Neurol 230:207-217.
49. Rafii MS, Hagiwara H, Mercado ML, Seo NS, Xu T, Dugan T, Owens RT, Hook M, McQuillan DJ, Young MF, Fallon JR (2006) Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol 209:439-447.
50. Rossi SG, Rotundo RL (1993) Localization of "non-extractable" acetylcholinesterase to the vertebrate neuromuscular junction. J Biol Chem 268:19152-19159.
51. Rotundo RL (2003) Expression and localization of acetylcholinesterase at the neuromuscular junction. J Neurocytol 32:743-766.
52. Ryall JG, Schertzer JD, Lynch GS (2008) Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9:213-228.
53. Sanes JR, Lichtman JW (2001) Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2:791-805.
54. Smith CL, Mittaud P, Prescott ED, Fuhrer C, Burden SJ (2001) Src, Fyn, and Yes are not required for neuromuscular synapse formation but are necessary for stabilization of agrin-induced clusters of acetylcholine receptors. J Neurosci 21:3151-3160.
55. Stanco AM, Werle MJ (1997) Agrin and acetylcholine receptors are re-moved from abandoned synaptic sites at reinnervated frog neuromuscular junctions. J Neurobiol 33:999-1018.
56. Vincent A, McConville J, Farrugia ME, Newsom-Davis J (2004) Seronegative myasthenia gravis. Semin Neurol 24:125-133.
57. Watty A, Neubauer G, Dreger M, Zimmer M, Wilm M, Burden SJ (2000) The in vitro and in vivo phosphotyrosine map of activated MuSK. Proc Natl Acad Sci U S A 97:4585-4590.
58. Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133:4993-5000.
59. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549-1554.
60. Witzemann V (2006) Development of the neuromuscular junction. Cell Tissue Res 326:263-271.
61. Wu H, Xiong WC, Mei L (2010) To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137:1017-1033.
62. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:78-82.
63. Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC, Mei L (2008) LRP4 serves as a coreceptor of agrin. Neuron 60:285-297.
64. Zhou H, Glass DJ, Yancopoulos GD, Sanes JR (1999) Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations. J Cell Biol 146:1133-1146.